• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Livongo Founder Glen Tullman to Receive “Ripple of Hope” Award

by Fred Pennic 08/20/2019 Leave a Comment

Livongo Founder Glen Tullman to Receive "Ripple of Hope" Award
Glen Tullman, Livongo Founder and Executive Chairman

Livongo Founder and Executive Chairman Glen Tullman will be honored with a Robert F. Kennedy Human Rights Ripple of Hope Award for his career focused on improving the safety, empathy, and efficiency of our healthcare system. 

The Ripple of Hope Award Background

The Ripple of Hope Award celebrates leaders of the international business, entertainment, and activist communities who have demonstrated a commitment to social change. Past honorees include President Barack Obama, Archbishop Desmond Tutu, Bono, George Clooney, and Robert F. Smith. Each honoree reflects Robert Kennedy’s passion for equality, justice, basic human rights, and his belief that we all must strive to “make gentle the life of this world.” 

Glen Tullman Bio

As the Founder and Executive Chairman of Livongo, Tullman has built the leading consumer-first digital health company focused on empowering people with chronic conditions to live better and healthier lives. His efforts to, for the first time at scale, bring together health and technology, have created a new category of Applied Health Signals, blending everything we love about consumer technology companies with the care and empathy so critical in health. Through a combination of data science, behavior enablement, and clinical impact, Livongo offers Members consumer-friendly solutions and personalized insights that make it easier to stay healthy. The Livongo approach has demonstrated that it can deliver better clinical and financial outcomes while creating a different and better experience for people with chronic conditions.

“When my son Sam was diagnosed with diabetes more than 17 years ago, I promised him that I would do everything in my power to help find a cure for diabetes and make it easier to stay healthy until we do. But as I learned about diabetes and its devastating impact on so many people, especially those who are under-resourced, it became about much more than Sam. Our vision was about creating a new kind of experience for people with chronic conditions that put them back in charge of their health and care. I am honored and humbled to accept the Robert F. Kennedy Human Rights Ripple of Hope Award on behalf of Sam and all people living with chronic conditions as we continue to work together to fulfill that promise,” said Tullman. “While we have made great progress in advocacy, research, and creating solutions that empower people with chronic conditions to live their best lives, but we are not yet finished. With 147 million people living with chronic conditions in the United States alone, we have more work to do to ensure we eradicate one of the largest societal epidemics today.” 

Prior to Livongo, Tullman spent more than two decades building and implementing technology-enabled solutions that revolutionized healthcare. As the former Chairman and Chief Executive Officer of Allscripts, Tullman built one of the leading providers of electronic health records, practice management, and e-prescribing solutions. During his tenure, Tullman helped create the first-ever free e-prescribing software, used to write millions of prescriptions every year, and helped eliminate thousands of injuries and deaths caused by prescription errors.

In addition, Tullman is the Managing Partner of 7wire Ventures, an early-stage venture firm focused on investing in disruptive, consumer-focused companies that improve both health and care.

The 51st annual RFK Human Rights Ripple of Hope ceremony will be held at a dinner on December 12, 2019 in New York City to honor laureates for their humanitarian advocacy around the globe.

Tagged With: Allscripts, Applied Health Signals, behavior, diabetes, digital health, f, Glen Tullman, HIM, honor, Livongo, Livongo Health

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |